Line of attack: NK cell specificity and integration of signals

Current Opinion in Immunology

Volumn 20, Issue 3, 2008, Pages 344-352

  Bryceson, Yenan T ^a,b   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL KILLER CELL RECEPTOR;

CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL SPECIFICITY; CELL TRANSFORMATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; EXOCYTOSIS; HUMAN; IMMUNE SYSTEM; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR; SIGNAL TRANSDUCTION;

EID: 45449115527     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.03.005     Document Type: Review

References (81)

1. Jonjic S., Babic M., Polic B., and Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol 20 (2008) 30-38
2. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5 (2004) 996-1002
3. Walzer T., Jaeger S., Chaix J., and Vivier E. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 19 (2007) 365-372
4. Adams G.P., and Weiner L.M. Monoclonal antibody therapy of cancer. Nat Biotechnol 23 (2005) 1147-1157
5. Carter P.J. Potent antibody therapeutics by design. Nat Rev Immunol 6 (2006) 343-357
6. Bottino C., Biassoni R., Millo R., Moretta L., and Moretta A. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering. Hum Immunol 61 (2000) 1-6
7. Arnon T.I., Achdout H., Lieberman N., Gazit R., Gonen-Gross T., Katz G., Bar-Ilan A., Bloushtain N., Lev M., Joseph A., et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103 (2004) 664-672
8. Nolte-'t Hoen E.N., Almeida C.R., Cohen N.R., Nedvetzki S., Yarwood H., and Davis D.M. Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication. Blood 109 (2007) 670-673. This report describes increased sensitivity of mitotic cells to NK cell surveillance, which could be a useful mechanism to control tumor growth or viral replication.
9. Moretta L., Ferlazzo G., Bottino C., Vitale M., Pende D., Mingari M.C., and Moretta A. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214 (2006) 219-228
10. Pogge von Strandmann E., Simhadri V.R., von Tresckow B., Sasse S., Reiners K.S., Hansen H.P., Rothe A., Boll B., Simhadri V.L., Borchmann P., et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27 (2007) 965-974. The long search for the elusive cellular ligand of natural cytotoxicity receptor NKp30 may have come to an end. A cytosolic protein, BAT3, which regulates apoptosis and proliferation, binds to NKp30 when exposed at the cell surface. A new set of interesting questions has been raised by these findings.
11. ••], this work suggests that NCR ligands may be expressed intracellularly.
12. Arnon T.I., Achdout H., Levi O., Markel G., Saleh N., Katz G., Gazit R., Gonen-Gross T., Hanna J., Nahari E., et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 6 (2005) 515-523
13. Mistry A.R., and O'Callaghan C.A. Regulation of ligands for the activating receptor NKG2D. Immunology 121 (2007) 439-447
14. Gasser S., Orsulic S., Brown E.J., and Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005) 1186-1190
15. Kaiser B.K., Yim D., Chow I.T., Gonzalez S., Dai Z., Mann H.H., Strong R.K., Groh V., and Spies T. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447 (2007) 482-486. Downmodulation of NKG2D in cancer patients due to the shedding of soluble NKG2D ligands hinders natural immunity to tumors. The identification of Erp5 as responsible for the release of NKG2D ligands provides a potential target for therapeutic inhibition of this immune evasion by tumor cells.
16. Smyth M.J., Swann J., Cretney E., Zerafa N., Yokoyama W.M., and Hayakawa Y. NKG2D function protects the host from tumor initiation. J Exp Med 202 (2005) 583-588
17. Ogasawara K., Hamerman J.A., Ehrlich L.R., Bour-Jordan H., Santamaria P., Bluestone J.A., and Lanier L.L. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20 (2004) 757-767
18. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., Lanier L.L., Groh V., Spies T., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
19. Reymond N., Imbert A.M., Devilard E., Fabre S., Chabannon C., Xerri L., Farnarier C., Cantoni C., Bottino C., Moretta A., et al. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J Exp Med 199 (2004) 1331-1341
20. Fuchs A., and Colonna M. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin Cancer Biol 16 (2006) 359-366
21. Cao E., Ramagopal U.A., Fedorov A., Fedorov E., Yan Q., Lary J.W., Cole J.L., Nathenson S.G., and Almo S.C. NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. Immunity 25 (2006) 559-570
22. Velikovsky C.A., Deng L., Chlewicki L.K., Fernandez M.M., Kumar V., and Mariuzza R.A. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. Immunity 27 (2007) 572-584
23. Welte S., Kuttruff S., Waldhauer I., and Steinle A. Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat Immunol 7 (2006) 1334-1342. This report identifies AICL, which is expressed on myeloid cells, as a ligand for the activation receptor NKp80. This interaction may provide an important means of crosstalk between NK cells and monocytes during inflammation.
24. Ljunggren H.G., and Malmberg K.J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7 (2007) 329-339
25. Sullivan L.C., Clements C.S., Beddoe T., Johnson D., Hoare H.L., Lin J., Huyton T., Hopkins E.J., Reid H.H., Wilce M.C., et al. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. Immunity 27 (2007) 900-911
26. •]
27. Grundemann C., Bauer M., Schweier O., von Oppen N., Lassing U., Saudan P., Becker K.F., Karp K., Hanke T., Bachmann M.F., et al. Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol 176 (2006) 1311-1315. These two papers report the identification of cadherins as ligands for the lectin-like inhibitory receptor KLRG1. Of note, cadherins are often downregulated on metastatic tumors.
28. Iizuka K., Naidenko O.V., Plougastel B.F., Fremont D.H., and Yokoyama W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 4 (2003) 801-807
29. Carlyle J.R., Jamieson A.M., Gasser S., Clingan C.S., Arase H., and Raulet D.H. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci U S A 101 (2004) 3527-3532
30. Aldemir H., Prod'homme V., Dumaurier M.J., Retiere C., Poupon G., Cazareth J., Bihl F., and Braud V.M. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 175 (2005) 7791-7795
31. Rosen D.B., Bettadapura J., Alsharifi M., Mathew P.A., Warren H.S., and Lanier L.L. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol 175 (2005) 7796-7799
32. Lebbink R.J., de Ruiter T., Adelmeijer J., Brenkman A.B., van Helvoort J.M., Koch M., Farndale R.W., Lisman T., Sonnenberg A., Lenting P.J., et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 203 (2006) 1419-1425. This paper reports that collagen is the cellular ligand of LAIR-1. This surprising finding represents the first extracellular ligand for inhibitory receptors. As many immune cells express LAIR-1, further analyses of the functional implications of this receptor are of upmost interest.
33. Bryceson Y.T., March M.E., Barber D.F., Ljunggren H.G., and Long E.O. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 202 (2005) 1001-1012
34. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166. This paper reports that, among several receptors tested, none is sufficient to induce natural cytotoxicity toward target cells. Instead, only certain synergistic combinations of receptors achieved degranulation and target cell lysis. The term 'co-activation receptor' has been proposed to describe these 'non-activating' receptors.
35. Cao W., Zhang L., Rosen D.B., Bover L., Watanabe G., Bao M., Lanier L.L., and Liu Y.J. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol 5 (2007) e248
36. Colucci F., Schweighoffer E., Tomasello E., Turner M., Ortaldo J.R., Vivier E., Tybulewicz V.L., and Di Santo J.P. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol 3 (2002) 288-294
37. Chiesa S., Mingueneau M., Fuseri N., Malissen B., Raulet D.H., Malissen M., Vivier E., and Tomasello E. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107 (2006) 2364-2372. This article elegantly demonstrates how multiplicity and the plasticity of the pathways that initiate NK cell effector functions contrast with the situation in other lymphocytes and provides an explanation for the resiliency of NK cell effector functions to various pharmacologic inhibitors and genetic mutations in signaling molecules.
38. Tassi I., Presti R., Kim S., Yokoyama W.M., Gilfillan S., and Colonna M. Phospholipase C-{gamma}2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol 175 (2005) 749-754
39. Caraux A., Kim N., Bell S.E., Zompi S., Ranson T., Lesjean-Pottier S., Garcia-Ojeda M.E., Turner M., and Colucci F. Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 107 (2006) 994-1002
40. Regunathan J., Chen Y., Kutlesa S., Dai X., Bai L., Wen R., Wang D., and Malarkannan S. Differential and nonredundant roles of phospholipase Cgamma2 and phospholipase Cgamma1 in the terminal maturation of NK cells. J Immunol 177 (2006) 5365-5376
41. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214 (2006) 73-91
42. •].
43. Tassi I., Cella M., Gilfillan S., Turnbull I., Diacovo T.G., Penninger J.M., and Colonna M. p110gamma and p110delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells. Immunity 27 (2007) 214-227. These two papers demonstrate that knockout of both PI3K p110γ and p110δ subunits impair NK development and activation.
44. Upshaw J.L., Arneson L.N., Schoon R.A., Dick C.J., Billadeau D.D., and Leibson P.J. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat Immunol 7 (2006) 524-532. Signaling through the DAP10 subunit of the natural cytotoxicity receptor NKG2D occurs by recruitment of a Grb2-Vav1 complex to the YxxM motif, in addition to PI3K recruitment.
45. Giurisato E., Cella M., Takai T., Kurosaki T., Feng Y., Longmore G.D., Colonna M., and Shaw A.S. Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse. Mol Cell Biol 27 (2007) 8583-8599
46. Horng T., Bezbradica J.S., and Medzhitov R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat Immunol 8 (2007) 1345-1352. An unexpected crosstalk in signals from the IL-15 receptor and NKG2D is reported in this paper. Downregulation of NKG2D/DAP10 impaired IL-15 responses. IL-15 alone induces DAP10 phosphorylation through the kinase Jak3.
47. •]
48. Masilamani M., Nguyen C., Kabat J., Borrego F., and Coligan J.E. CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse. J Immunol 177 (2006) 3590-3596
49. Fassett M.S., Davis D.M., Valter M.M., Cohen G.B., and Strominger J.L. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc Natl Acad Sci U S A 98 (2001) 14547-14552
50. Watzl C., and Long E.O. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J Exp Med 197 (2003) 77-85
51. Endt J., McCann F.E., Almeida C.R., Urlaub D., Leung R., Pende D., Davis D.M., and Watzl C. Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. J Immunol 178 (2007) 5606-5611
52. Stebbins C.C., Watzl C., Billadeau D.D., Leibson P.J., Burshtyn D.N., and Long E.O. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 23 (2003) 6291-6299
53. Treanor B., Lanigan P.M., Kumar S., Dunsby C., Munro I., Auksorius E., Culley F.J., Purbhoo M.A., Phillips D., Neil M.A., et al. Microclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapses. J Cell Biol 174 (2006) 153-161. High sensitivity imaging of phosphorylated ITIM-containing KIR at inhibitory NK cell immune synapses has been achieved. Surprisingly, phosphorylated KIR, presumably bound to active SHP-1, is distributed in small clusters over the synapse, which does not correspond to the distribution of total KIR. These findings raise interesting questions about the mechanism of inhibition.
54. Verbrugge A., Rijkers E.S., de Ruiter T., and Meyaard L. Leukocyte-associated Ig-like receptor-1 has SH2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase. Eur J Immunol 36 (2006) 190-198. Inhibition by the ITIM-containing receptor LAIR-1 can occur in the absence of SHP-1, SHP-2, and SHIP binding through the recruitment of the kinase Csk. Csk mediates negative regulation of Src-family kinases by phosphorylation of their C-terminal tyrosine.
55. Orange J.S. The lytic NK cell immunological synapse and sequential steps in its formation. Adv Exp Med Biol 601 (2007) 225-233
56. Stinchcombe J.C., Majorovits E., Bossi G., Fuller S., and Griffiths G.M. Centrosome polarization delivers secretory granules to the immunological synapse. Nature 443 (2006) 462-465. Polarization of cytotoxic granules in T cells occurs by movement of the microtubule organizing center (MTOC) toward the target cell, and centrosomes contact with the plasma membrane. Granules do not move toward the plus end of microtubules, but toward the MTOC in the minus direction.
57. Banerjee P.P., Pandey R., Zheng R., Suhoski M.M., Monaco-Shawver L., and Orange J.S. Cdc42-interacting protein-4 functionally links actin and microtubule networks at the cytolytic NK cell immunological synapse. J Exp Med 204 (2007) 2305-2320. The Cdc42-interacting protein-4 (CIP4) is identified as a crucial link between actin cytoskeleton and microtubles, mediating granule polarization and cytotoxicity.
58. Krzewski K., Chen X., and Strominger J.L. WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proc Natl Acad Sci U S A 105 (2008) 2568-2573
59. •] demonstrate a role for myosin IIA in NK cell cytotoxicity. Notably, myosin IIA is required for exocytosis, but not polarization, of secretory lysosomes.
60. Fischer A., Latour S., and de Saint Basile G. Genetic defects affecting lymphocyte cytotoxicity. Curr Opin Immunol 19 (2007) 348-353
61. Crozat K., Hoebe K., Ugolini S., Hong N.A., Janssen E., Rutschmann S., Mudd S., Sovath S., Vivier E., and Beutler B. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J Exp Med 204 (2007) 853-863
62. Menager M.M., Menasche G., Romao M., Knapnougel P., Ho C.H., Garfa M., Raposo G., Feldmann J., Fischer A., and de Saint Basile G. Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4. Nat Immunol 8 (2007) 257-267. This study provides evidence for fusion of distinct vesicular compartments, which then form the secretory lysosomes that fuse with the plasma membrane for degranulation. These results challenge the notion of direct transport of secretory lysosomes to the plasma membrane for fusion.
63. Gazit R., Aker M., Elboim M., Achdout H., Katz G., Wolf D.G., Katzav S., and Mandelboim O. NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. Blood 109 (2007) 4306-4312
64. Marcenaro S., Gallo F., Martini S., Santoro A., Griffiths G.M., Arico M., Moretta L., and Pende D. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood 108 (2006) 2316-2323
65. Rudd E., Bryceson Y.T., Zheng C., Edner J., Wood S.M., Ramme K., Gavhed S., Gurgey A., Hellebostad M., Bechensteen A., et al. Spectrum, and clinical and functional implications of UNC13D mutations in familial hemophagocytic lymphohistiocytosis. J Med Genet 45 (2007) 134-141
66. •].
67. Arneson L.N., Brickshawana A., Segovis C.M., Schoon R.A., Dick C.J., and Leibson P.J. Cutting edge: syntaxin 11 regulates lymphocyte-mediated secretion and cytotoxicity. J Immunol 179 (2007) 3397-3401. Mutations in syntaxin 11, a SNARE motif containing protein, cause familial hemophagocytic lymphohistiocytosis type 4, an immune disorder characterized by hyperinflammation and susceptibility to certain intracellular pathogens. These two papers show that syntaxin 11 is essential for degranulation of NK cells, thereby providing a mechanistic explanation for the disease.
68. •].
69. Gross O., Grupp C., Steinberg C., Zimmermann S., Strasser D., Hannesschlager N., Reindl W., Jonsson H., Huo H., Littman D.R., et al. Multiple ITAM-coupled NK cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-{kappa}B and MAPK activation to selectively control cytokine production. Blood (2008) [Epub ahead of print]. These two papers identify a key 'molecular switch' that separates activation of cytokine production from cytotoxicity in NK cells. The Bcl10-Malt1-Carma1 pathway controls production of GM-CSF, IFN-γ, and chemokines, but neither NK cell development nor target cell killing is controlled.
70. Huntington N.D., Xu Y., Nutt S.L., and Tarlinton D.M. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J Exp Med 201 (2005) 1421-1433
71. Hesslein D.G., Takaki R., Hermiston M.L., Weiss A., and Lanier L.L. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc Natl Acad Sci U S A 103 (2006) 7012-7017
72. Mason L.H., Willette-Brown J., Taylor L.S., and McVicar D.W. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J Immunol 176 (2006) 6615-6623
73. +NKT cells regulated by the Src kinase Fgr. Blood 107 (2006) 3647-3655
74. Trotta R., Ciarlariello D., Dal Col J., Allard II J., Neviani P., Santhanam R., Mao H., Becknell B., Yu J., Ferketich A.K., et al. The PP2A inhibitor SET regulates natural killer cell IFN-gamma production. J Exp Med 204 (2007) 2397-2405
75. Rajagopalan S., Bryceson Y.T., Kuppusamy S.P., Geraghty D.E., van der Meer A., Joosten I., and Long E.O. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 4 (2006) e9. A potential function of KIR2DL4 in promoting neo-vascularization during early pregnancy is revealed in this study. KIR2DL4 signals for a pro-inflammatory/pro-angionenic response of resting cells from endosomes, into which it has internalized its ligand, soluble HLA-G.
76. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., and Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105 (2005) 4416-4423
77. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., Breso V., Frassati C., Reviron D., Middleton D., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25 (2006) 331-342. As previously demonstrated in mice, these results show that NK cells lacking inhibitory receptors for MHC class I are found in circulation but are functionally hyporesponsive. Together with data from animal models, these data reveal the impact of inhibitory receptor-MHC class I interactions on the potency of individual NK cells.
78. Yokoyama W.M., and Kim S. How do natural killer cells find self to achieve tolerance?. Immunity 24 (2006) 249-257
79. Gasser S., and Raulet D.H. Activation and self-tolerance of natural killer cells. Immunol Rev 214 (2006) 130-142
80. Fehniger T.A., Cai S.F., Cao X., Bredemeyer A.J., Presti R.M., French A.R., and Ley T.J. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity 26 (2007) 798-811
81. Lucas M., Schachterle W., Oberle K., Aichele P., and Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26 (2007) 503-517. Unexpectedly, mouse NK cells do not mount effective responses unless stimulated by dendritic cells trans-presenting IL-15. The data reveal a requirement for priming of NK cells, analogous to T cell responses.